Unrealistic Optimism in Early-Phase Oncology Trials
A new report questions the ethics of early stage oncology clinical trials, asserting that since patients have unrealistically high expectations of the outcomes of the trials, a question of informed consent is raised.
According to the LA Times,
- 60% were unrealistically optimistic that the drug being tested would control their cancer
- 63% were unrealistically optimistic that the experimental drug would improve their health in some way
- 39% were unrealistically optimistic that they wouldn’t experience harmful side effects from the drugs in their trials
The abstract of the report is available here